相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Functional characterization of a DNA-dependent AAA ATPase in a F-cluster mycobacteriophage
Ritam Das et al.
VIRUS RESEARCH (2023)
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2022)
Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward
Ganesh Kumraj et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)
Combination Effect of Engineered Endolysin EC340 With Antibiotics
Hye-Won Hong et al.
FRONTIERS IN MICROBIOLOGY (2022)
Novel Phage Lysin Abp013 against Acinetobacter baumannii
Joash Jun Keat Chu et al.
ANTIBIOTICS-BASEL (2022)
Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19
Ritam Das et al.
INFECTIOUS DISEASES AND THERAPY (2022)
Evaluation of factors influencing expression and extraction of recombinant bacteriophage endolysins in Escherichia coli
Cecilia Lucia Balaban et al.
MICROBIAL CELL FACTORIES (2022)
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
Matteo Bassetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
In Silico Development of Novel Chimeric Lysins with Highly Specific Inhibition against Salmonella by Computer-Aided Design
Ting Nie et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India
Sanjeev Singh et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2021)
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?
Soumya Ghosh et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Rapid and High-Throughput Evaluation of Diverse Configurations of Engineered Lysins Using the VersaTile Technique
Lisa Duyvejonck et al.
ANTIBIOTICS-BASEL (2021)
Phage-Encoded Endolysins
Fatma Abdelrahman et al.
ANTIBIOTICS-BASEL (2021)
Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go
Diana Gutierrez et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design
Roberto Vazquez et al.
JOURNAL OF VIROLOGY (2021)
The Advantages and Challenges of Using Endolysins in a Clinical Setting
Ellen Murray et al.
VIRUSES-BASEL (2021)
Phage Endolysin LysP108 Showed Promising Antibacterial Potential Against Methicillin-resistant Staphylococcus aureus
Yifei Lu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
PhaLP: A Database for the Study of Phage Lytic Proteins and Their Evolution
Bjorn Criel et al.
VIRUSES-BASEL (2021)
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections
Vijay Singh Gondil et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Recombinant engineered phage-derived enzybiotic in Pichia pastoris X-33 as whole cell biocatalyst for effective biocontrol of Vibrio parahaemolyticus in aquaculture
Ramachandran Srinivasan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Recombinant Protein Production in Microalgae: Emerging Trends
Niaz Ahmad et al.
PROTEIN AND PEPTIDE LETTERS (2020)
Bacteriophages and Lysins in Biofilm Control
Marzanna Lusiak-Szelachowska et al.
VIROLOGICA SINICA (2020)
Phage Lytic Protein LysRODI Prevents Staphylococcal Mastitis in Mice
Diana Gutierrez et al.
FRONTIERS IN MICROBIOLOGY (2020)
A potent enzybiotic against methicillin-resistant Staphylococcus aureus
Jasjeet Kaur et al.
VIRUS GENES (2020)
In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens
Lucia Blasco et al.
SCIENTIFIC REPORTS (2020)
Exploring Endolysin-Loaded Alginate-Chitosan Nanoparticles as Future Remedy for Staphylococcal Infections
Jasjeet Kaur et al.
AAPS PHARMSCITECH (2020)
A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins
H. Gerstmans et al.
SCIENCE ADVANCES (2020)
Advanced engineering of third-generation lysins and formulation strategies for clinical applications
Vincent De Maesschalck et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2020)
Exploiting phage receptor binding proteins to enable endolysins to kill Gram-negative bacteria
Athina Zampara et al.
SCIENTIFIC REPORTS (2020)
LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity
Shukho Kim et al.
VIRUSES-BASEL (2020)
Antimicrobial use in food animals and human health: time to implement 'One Health' approach
Sunil Pokharel et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
Bacteriophage-derived endolysins to target gram-negative bacteria
Wing Ching Bianca Lai et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Gram-Negative Bacterial Lysins
Chandrabali Ghose et al.
ANTIBIOTICS-BASEL (2020)
Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection
Assaf Raz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria
Ryan D. Heselpoth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
External lysis of Escherichia coli by a bacteriophage endolysin modified with hydrophobic amino acids
Guangmou Yan et al.
AMB EXPRESS (2019)
Preparation and characterization of endolysin-containing liposomes and evaluation of their antimicrobial activities against gram-negative bacteria
Jaewoo Bai et al.
ENZYME AND MICROBIAL TECHNOLOGY (2019)
Therapeutic Potential of an Endolysin Derived from Kayvirus S25-3 for Staphylococcal Impetigo
Ichiro Imanishi et al.
VIRUSES-BASEL (2019)
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
Carolina Iglesias-Lopez et al.
FRONTIERS IN PHARMACOLOGY (2019)
Antibiotics: past, present and future
Matthew I. Hutchings et al.
CURRENT OPINION IN MICROBIOLOGY (2019)
A Novel Phage PD-6A3, and Its Endolysin Ply6A3, With Extended Lytic Activity Against Acinetobacter baumannii
Minle Wu et al.
FRONTIERS IN MICROBIOLOGY (2019)
Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development
Nagesh K. Tripathi et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Inhibitory and bactericidal effect of Artilysin® Art-175 against colistin-resistant mcr-1-positive Escherichia coli isolates
Eva Schirmeier et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
In vitro characterization of PlyE146, a novel phage lysin that targets Gram-negative bacteria
Yu Larpin et al.
PLOS ONE (2018)
Thousands of Novel Endolysins Discovered in Uncultured Phage Genomes
Iris Fernandez-Ruiz et al.
FRONTIERS IN MICROBIOLOGY (2018)
Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection
Nak-Hyun Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci
Yufeng Zhang et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
Plant-expressed bacteriophage lysins control pathogenic strains of Clostridium perfringens
Vaiva Kazanaviciute et al.
SCIENTIFIC REPORTS (2018)
Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
Roberto Vazquez et al.
FRONTIERS IN IMMUNOLOGY (2018)
Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies
Hamed Haddad Kashani et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care
Michael J. Love et al.
ANTIBIOTICS-BASEL (2018)
Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus
Qiang Ma et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2017)
Klebsiella phages representing a novel clade of viruses with an unknown DNA modification and biotechnologically interesting enzymes
Barbara Maciejewska et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
The antibacterial activity of E-coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region
Shuang Wang et al.
JOURNAL OF MICROBIOLOGY (2017)
Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii
Laura Stoffels et al.
PLANT BIOTECHNOLOGY JOURNAL (2017)
Modular endolysin of Burkholderia AP3 phage has the largest lysozyme-like catalytic subunit discovered to date and no catalytic aspartate residue
Barbara Maciejewska et al.
SCIENTIFIC REPORTS (2017)
A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
Mingquan Guo et al.
FRONTIERS IN MICROBIOLOGY (2017)
A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus
Hang Yang et al.
SCIENTIFIC REPORTS (2017)
Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2
Shih-Yi Peng et al.
SCIENTIFIC REPORTS (2017)
The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly
Guangmou Yan et al.
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY (2017)
Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections
D. P. Pires et al.
CURRENT OPINION IN MICROBIOLOGY (2017)
A Review on Antibiotic Resistance: Alarm Bells are Ringing
Sojib Bin Zaman et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2017)
Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii
Valerie Defraine et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii
Mya Thandar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In vitro study of the antibacterial effect of the bacteriophage T5 thermostable endolysin on Escherichia coli cells
M. S. Shavrina et al.
JOURNAL OF APPLIED MICROBIOLOGY (2016)
High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives
Baolei Jia et al.
OPEN BIOLOGY (2016)
Enhanced Antibacterial Activity of Acinetobacter baumannii Bacteriophage OABP-01 Endolysin (LysABP-01) in Combination with Colistin
Rapee Thummeepak et al.
FRONTIERS IN MICROBIOLOGY (2016)
Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics
Callum J. Cooper et al.
FRONTIERS IN MICROBIOLOGY (2016)
Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity
Hugo Oliveira et al.
FRONTIERS IN MICROBIOLOGY (2016)
LysGH15 kills Staphylococcus aureus wLeithout being affected by the humoral immune response or inducing inflammation
Lei Zhang et al.
SCIENTIFIC REPORTS (2016)
Optimising Antibiotic Usage to Treat Bacterial Infections
Iona K. Paterson et al.
SCIENTIFIC REPORTS (2016)
Novel Phage Lysin Capable of Killing the Multidrug-Resistant Gram-Negative Bacterium Acinetobacter baumannii in a Mouse Bacteremia Model
Rolf Lood et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae
Roberto Diez-Martinez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Genome sequencing and analysis of an Escherichia coli phage vB_EcoM-ep3 with a novel lysin, Lysep3
Meng Lv et al.
VIRUS GENES (2015)
Novel Chimeric Lysin with High-Level Antimicrobial Activity against Methicillin-Resistant Staphylococcus aureus In Vitro and In Vivo
Hang Yang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Art-175 Is a Highly Efficient Antibacterial against Multidrug-Resistant Strains and Persisters of Pseudomonas aeruginosa
Yves Briers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient
Soo Youn Jun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1)
Guangtao Huang et al.
BMC INFECTIOUS DISEASES (2014)
Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus-Induced Murine Bacteremia
Raymond Schuch et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Engineered Endolysin-Based Artilysins To Combat Multidrug-Resistant Gram-Negative Pathogens
Yves Briers et al.
MBIO (2014)
Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem
Carl Llor et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2014)
Bacteriophage-encoded lytic enzymes control growth of contaminating Lactobacillus found in fuel ethanol fermentations
Dwayne R. Roach et al.
BIOTECHNOLOGY FOR BIOFUELS (2013)
Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives
Sergio Rosales-Mendoza et al.
PLANT CELL REPORTS (2012)
Antibacterial activity of Acinetobacter baumannii phage ΦAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria
Meng-Jiun Lai et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa
Y. Briers et al.
JOURNAL OF APPLIED MICROBIOLOGY (2011)
Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications
Maria do Carmo de Freire Bastos et al.
PHARMACEUTICALS (2010)
The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144
Yves Briers et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Colistin in the 21st century
Roger L. Nation et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2009)
Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic
Melanie Oey et al.
PLANT JOURNAL (2009)
Bacteriophage lysins as effective antibacterials
Vincent A. Fischetti
CURRENT OPINION IN MICROBIOLOGY (2008)
Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure
Yves Briers et al.
FEMS MICROBIOLOGY LETTERS (2008)
Taking aim on bacterial pathogens: from phage therapy to enzybiotics
Juan A. Hermoso et al.
CURRENT OPINION IN MICROBIOLOGY (2007)
Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phi KZ gp144 lytic transglycosylase
Catherine Paradis-Bleau et al.
FEMS MICROBIOLOGY LETTERS (2007)
A bacteriolytic agent that detects and kills Bacillus anthracis
R Schuch et al.
NATURE (2002)
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase
JM Loeffler et al.
SCIENCE (2001)
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme
D Nelson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
